{"transactions":[{"id":1236232,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":82571,"kind":"person","name":"Duffield Jeremy","position":1,"cik":"0001922590","reported_name":"Duffield Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-03T20:15:39.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":275000,"derivative":{"exercise_price":2.42,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001894562-25-000008","document":"wk-form4_1741050933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922590/000189456225000008/wk-form4_1741050933.xml","form_type":"4"}},{"id":1622897,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":82571,"kind":"person","name":"Duffield Jeremy","position":1,"cik":"0001922590","reported_name":"Duffield Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-23T17:03:20.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":180995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 21, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":180995,"derivative":{"exercise_price":8.49,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":180995},"source":{"system":"sec-edgar","filing":"0001894562-24-000013","document":"wk-form4_1708725783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922590/000189456224000013/wk-form4_1708725783.xml","form_type":"4"}},{"id":1929077,"issuer":{"id":5281,"kind":"organization","name":"Prime Medicine, Inc."},"owners":[{"id":82571,"kind":"person","name":"Duffield Jeremy","position":1,"cik":"0001922590","reported_name":"Duffield Jeremy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-04T20:23:08.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":180995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 31, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":180995,"derivative":{"exercise_price":12.3,"expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":180995},"source":{"system":"sec-edgar","filing":"0001894562-23-000005","document":"wf-form4_168065417838934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922590/000189456223000005/wf-form4_168065417838934.xml","form_type":"4"}}]}